Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Pizaccord Pioglitazone hydrochloride 16.53mg equivalent to pioglitazone 15mg Tablet Douglas Pharmaceuticals Limited Intas Pharmaceuticals Limited, Ahmedabad, India
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Pizaccord Pioglitazone hydrochloride 33.07mg equivalent to pioglitazone 30mg Tablet Douglas Pharmaceuticals Limited Intas Pharmaceuticals Limited, Ahmedabad, India
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Pizaccord Pioglitazone hydrochloride 49.6mg equivalent to pioglitazone 45mg Tablet Douglas Pharmaceuticals Limited Intas Pharmaceuticals Limited, Ahmedabad, India
|
Dated this 2nd day of February 2018.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).